Ocelot Bio

Ocelot Bio, Inc. is a clinical-stage biopharmaceutical company dedicated to providing meaningful therapeutic interventions for patients urgently in need due to complications of decompensated (end-stage) cirrhosis, particularly hepatorenal syndrome-acute kidney injury (HRS-AKI) and refractory ascites.